Brief: Inotiv Inc Announces Acquisition Of Protypia Inc
07/07/2022 21:12
July 7 (Reuters) - Inotiv Inc NOTV.O :
* INOTIV, INC. EXPANDS PROTEIN/PEPTIDE BIOANALYTICAL
CAPABILITIES
WITH ACQUISITION OF PROTYPIA, INC.
* INOTIV INC - TRANSACTION CONSIDERATION TOTALED
APPROXIMATELY
$11.0 MILLION
* INOTIV INC - EXPECTS TO RETAIN ALL EXISTING PROTYPIA
EMPLOYEES
AND MAINTAIN OPERATIONS IN NASHVILLE, TN.
Source text for Eikon: ID:nGNX5KnkZD
Further company coverage: NOTV.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inotiv
See all newsBrief: Inotiv Reaches Agreement To Strengthen Capital Structure And Position Company For Future Growth
Brief: Inotiv Inc Enters $40 Million Bridge Facility Under Ninth Amendment To Credit Agreement
Contract research firm Inotiv's Q1 operating loss widens
Brief: Inotiv Q1 Revenue USD 120.9 Million
Drug testing services firm Inotiv's Q4 revenue beats estimates